306 related articles for article (PubMed ID: 8093132)
1. Lack of pharmacologic tolerance and rebound angina pectoris during twice-daily therapy with isosorbide-5-mononitrate.
Thadani U; Maranda CR; Amsterdam E; Spaccavento L; Friedman RG; Chernoff R; Zellner S; Gorwit J; Hinderaker PH
Ann Intern Med; 1994 Mar; 120(5):353-9. PubMed ID: 8093132
[TBL] [Abstract][Full Text] [Related]
2. Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
Thadani U; Bittar N
Am J Cardiol; 1992 Aug; 70(3):286-92. PubMed ID: 1632390
[TBL] [Abstract][Full Text] [Related]
3. Eccentric dosing with isosorbide-5-mononitrate in angina pectoris.
Parker JO
Am J Cardiol; 1993 Oct; 72(12):871-6. PubMed ID: 8213541
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
[TBL] [Abstract][Full Text] [Related]
5. A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina.
Walker JM; Curry PV; Bailey AE; Steare SE
Int J Cardiol; 1996 Feb; 53(2):117-26. PubMed ID: 8682597
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
Thadani U; Prasad R; Hamilton SF; Voyles W; Doyle R; Karpow S; Reder R; Teague SM
Am J Cardiol; 1987 Sep; 60(7):477-82. PubMed ID: 3630929
[TBL] [Abstract][Full Text] [Related]
7. Once- versus twice-daily administration of controlled-release isosorbide-5-mononitrate 60 mg in the treatment of stable angina pectoris. A randomized, double-blind, cross-over study. The Swedish Multicentre Group.
Nordlander R; Walter M
Eur Heart J; 1994 Jan; 15(1):108-13. PubMed ID: 8174569
[TBL] [Abstract][Full Text] [Related]
8. Isosorbide 5-mononitrate: a review of a sustained-release formulation (Imdur) in stable angina pectoris.
Gunasekara NS; Noble S
Drugs; 1999 Feb; 57(2):261-77. PubMed ID: 10188765
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of a controlled-release formulation of isosorbide-5-mononitrate and conventional isosorbide dinitrate on exercise performance in men with stable angina pectoris.
Seabra-Gomes R; Aleixo AM; Adao M; Machado FP; Mendes M; Bruges G; Palos JL
Am J Cardiol; 1990 Jun; 65(20):1308-12. PubMed ID: 2188493
[TBL] [Abstract][Full Text] [Related]
10. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
Chen YH; Ding PY; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
[TBL] [Abstract][Full Text] [Related]
11. Effect of extended-release isosorbide mononitrate one hour after dosing in patients with stable angina pectoris. IMDUR Study Group.
Glasser SP
Am J Cardiol; 1997 Dec; 80(12):1546-50. PubMed ID: 9416933
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of isosorbide mononitrate in angina pectoris.
Thadani U; de Vane PJ
Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
[TBL] [Abstract][Full Text] [Related]
13. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
Parker JO
Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
[TBL] [Abstract][Full Text] [Related]
14. [Isosorbide-5-mononitrate in angina pectoris: its efficacy and absence of tolerance and rebound with an eccentric type of administration].
Schneeweiss A; Reisin L; Marmor A; Caspi A
Cardiology; 1994; 84 Suppl 1():4-12. PubMed ID: 8087823
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in a slow-release form on exercise-induced myocardial ischemia.
Hennig L; Andresen D; Hennig A; Levenson B; Brüggemann T; Schröder R
J Clin Pharmacol; 1991 Jul; 31(7):636-40. PubMed ID: 1894759
[TBL] [Abstract][Full Text] [Related]
16. Abrupt withdrawal of isosorbide-5-mononitrate in Durules (Imdur) after long term treatment in patients with stable angina pectoris.
Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Reinikainen P
Eur Heart J; 1988 Dec; 9(12):1339-47. PubMed ID: 3147892
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of controlled-release isosorbide-5-mononitrate in Japanese patients with stable effort angina pectoris.
Shimada K; Sunayama S; Nakazato K; Satoh H; Kusama Y; Kawakubo K; Daida H
Int Heart J; 2006 Sep; 47(5):695-705. PubMed ID: 17106140
[TBL] [Abstract][Full Text] [Related]
18. Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris.
Kohli RS; Rodrigues EA; Kardash MM; Whittington JR; Raftery EB
Am J Cardiol; 1986 Oct; 58(9):727-31. PubMed ID: 3766413
[TBL] [Abstract][Full Text] [Related]
19. Slow-release isosorbide-5-mononitrate--a new once daily therapeutic modality for angina pectoris.
Ahmadinejad M; Eghbal B; Sorgenicht W; Schneeweiss A; Weiss M
Eur Heart J; 1988 Jan; 9 Suppl A():135-9. PubMed ID: 3137063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
